Attempts were made to establish models to study interactions between marrow stromal cells and hematopoietic cells in vivo. The approach was to create a NOD-SCID-hu murine model of long-term human hematopoiesis by implantation of a human adult bone fragment. Nine to 12 weeks posttransplantation, human CD45 + cells were detected in the blood and the spleen of some mice. The histology of the human transplant showed that human bone fragment was viable at 9 weeks. Moreover, vessels of human origin, as assessed by immunohistochemical detection of human β 2 -microglobulin, were observed in the mouse tissue surrounding the transplanted human fragment.
INTRODUCTION
in SCID mice and also administered human cytokines at the site of bone implantation and detected circulating human cells in SCID mice only for the duration of cyto-The understanding of the role of bone marrow microenvironment in human hematopoiesis has been ham-kine administration. Implantation of adult bone in the absence of cytokine administration has failed (3). How-pered due to lack of a good animal model. Several approaches have been used to develop an animal model of ever, the regular administration of cytokines may skew the differentiation of human bone marrow cell pop-human hematopoiesis including the engraftment of human hematopoietic cells into severe combined immuno-ulations. Several approaches have been tried to overcome the deficient (SCID) mice (5-7,10,16). But by using adult and fetal hematopoietic cells only a limited degree of SCID mouse immune barrier to human hematopoietic cells. The first one was to implant adult human bone in human hematopoiesis was observed (8). There may be at least two explanations for this. First, the residual non-SCID mice pretreated with radiation and anti-asialo GM1 rabbit sera (13) , which showed clearly that the specific immune system of SCID mice (NK cells and macrophages) may be a barrier to the survival of hema-main barrier to the successful implantation of viable human tissues in SCID mice is host macrophages and NK topoietic cells (9) in the mouse and, second, the human hematopoietic microenvironment may be required for cells. An alternative is to implant human bone fragments into nonobese diabetes (NOD/SCID) mice, which are to-efficient human hematopoiesis.
The effect of human hematopoietic microenviron-tally immunodeficient (14) . Fujiki et al. implanted (2) human rib fragments in NOD/SCID and described a ment on hematopoiesis has been investigated in SCID mice. Human fetal bone was implanted into SCID mice. dominant expansion of human T lymphocytes in peripheral blood and fatty degeneration of marrow in the im-Fetal bone marrow cells were detected in the implanted bone and a small number of circulating human CD45 + planted bone fragments by 8 weeks. This approach also has some limitations. The human bones were obtained cells were found in the mouse blood but no data were provided on the infiltration of hematopoietic cells in from lung cancer patients wherein the bone marrow could present reactive changes in response to the pathol-other mouse tissues (7). Morever, this approach has limitations. Fetal tissues do not reflect adult hematopoietic ogy and/or the treatment. In our hypothesis, NOD/SCID mice would be better recipients for human bone marrow conditions (13, 14) . 
than SCID mice. No pretreatment is necessary to deplete Implantation of NOD/SCID Mice With Human Bone residual NK cells and macrophages of SCID mice and
Transplantation of bone into NOD/SCID mice was we postulate that adult bone marrow fragment containperformed within 2 h of procurement, under a general ing an intact hematopoietic microenvironment would anesthesia (Forene, S.A. Abbot). Human bone fragments sustain human hematopoiesis for several weeks.
were transplanted subcutaneously over the back of the We thus implanted normal human bone fragments animal. into NOD/SCID mice and we looked for human hemato-Tissue Processing for Histology and Preparation poiesis in these animals. The adult human bone fragment for Flow Cytometric Analysis implanted was viable and functional at 9 weeks posttransplant and human hematopoiesis was maintained for At various time points (4, 6, 8, 9, 10, and 12 weeks), 12 weeks. mice were killed by CO 2 inhalation. Three mice were used for each endpoint. The human bone marrow was MATERIALS AND METHODS removed and fixed in Histocon  (Polysciences Inc., Warrington, PA), embedded in Tissue-Tek  (O.C.T. Antibodies compound), and frozen at −80°C. Mouse IgG anti-human CD45 antibody (Becton Dick-
The peripheral blood was taken from the retro-orbital inson) conjugated with fluorescein isothiocyanate (FITC) sinus; bone marrow and spleen were collected. These was used to detect pan-leucocytes of human origin.
tissues were teased apart and passed through a tissue Mouse IgM anti-human β 2 -microglobulin antibody filter (Blutex, 60 µm) to remove debris. After lysis of (Pharmingen) stains human cells that express HLA class red blood cells with hypotonic saline solution (NH 4 Cl, I antigen complex. Rabbit IgM anti-mouse conjugated KHCO 3 , and EDTA), white cells were incubated for 30 with biotin was used to reveal the β 2 -microglobulin min at 4°C with a mouse anti-human CD45 antibody staining.
(mouse IgG conjugated with FITC), titrated with refer-Rabbit IgG anti-human von Willebrand factor antience cells and used at saturating concentrations, and anbody (Dako) was used to identify the presence of blood alyzed by flow cytometry. Cells were analyzed with a vessels. Goat IgG anti-rabbit conjugated with biotin FACStar plus (Becton Dickinson) equipped with an and peroxidase (Dakocytomation envision+  system laargon neon laser. Specific fluorescence of FITC excited beled polymer-HRP) was used to reveal the von Willeat 488 nm as well as forward and orthogonal light scatter brand factor staining. signals were used to establish sort windows. Listmode analysis was done by using the CellQuest program (Bec-Reagents ton Dickinson). Listmode data were obtained from more than 10,000 cells. Negative control consisted of addi-Avidin-biotin-peroxidase was obtained from Vector, diaminobenzidine (DAB) was purchased from Merck, tional aliquots of the same cells stained with irrelevant isotype-matched control antibody directly labeled with and bisbenzimide was from Sigma. the identical fluorochrome. Positive control was human blood cells incubated with mouse anti-human CD45 an-Mice tibody coupled to FITC. To separate human from mouse NOD/SCID mice were purchased from Jackson Labcells on the basis of their size, dot plot analysis was oratories (Bar Harbor, ME) and were maintained under performed on human lymphocytes isolated from a buffy specific pathogen-free conditions. Mice received nutricoat and on a cell suspension from murine spleen. To tional chow and water ad libitum and were used when determine the threshold of detection of FACS analysis, 6-8 weeks old. The experimental work was conducted human lymphocytes incubated for 30 min at 4°C with a according to the procedures outlined in the Law for Care mouse anti-human CD45 antibody conjugated with and Use of Laboratory Animals (Arrêté Royal, Novem-FITC were serially diluted in nonstained lymphocytes ber 14, 1993, Belgium) . and the lowest percentage detected by flow cytometry was evaluated.
Origin of Human Bone
Enzymology of Implanted Human Bone Cancellous bone was obtained from healthy volunteer patients (age range 12-52 years) during hip surgery us-For alkaline phosphatase activity detection, 5-µm cryostat sections were incubated in a reaction medium ing protocols approved by the Human Ethics Committee. Cancellous bone was obtained from the posterior containing 1 mg ml −1 fast blue BB salt, 0.3 mg ml −1 naphthol-AS-phosphate (both Sigma, Poole, UK), and iliac crest, minced in small fragments approximately 0.5 cm, and maintained under sterile conditions in RPMI-0.5% N,N-dimethylformamide in 0.2 M Tris buffer (pH 9.1). To reveal the chloroacetate esterase expression, 1640 medium (Life Technologies). specimens were incubated in a reaction medium containing 2% parafuchsin-hydrochloride (Fluka Chemie), 0.1 mg ml −1 naphthol-ASD-chloroacetate (Sigma, Poole, UK), and 1% N,N-dimethylformamide in 0.15 M Veronal buffer (pH 6.3).
Histology and Immunohistology of Implanted Human Bone
Endogenous peroxidase activity was inhibited by incubating the sections for 10 min in 3% H 2 O 2 . Parallel sections were incubated for 2 h at room temperature with a mouse anti-human β 2 -microglobulin antibody titrated with reference tissues and used at saturating concentrations, then with an anti-mouse IgM conjugated with biotin, and finally with avidin-biotin-peroxidase. After incubation in DAB, sections were counterstained with hematoxylin and eosin (Surgipath), mounted with entellan (Merck), and observed with a light microscope. Positive cells were stained in brown. For von Willebrand staining, endogenous peroxidase activity was also inhibited as described above. Sections were incubated for 30 min at room temperature with a rabbit anti-human von Willebrand antibody used at optimal dilutions, then with an anti-rabbit IgG coupled with biotin and peroxidase during 30 min. After incubation for 3 min in DAB, sections were counterstained with hematoxylin and eosin, mounted with entellan, and observed with a light microscope. Endothelial positive cells were stained in brown.
For immunofluorescence, sections were incubated with a mouse anti-human CD45 antibody coupled with FITC. Positive cells were green cells. Nuclei were coun- To develop an animal model for human hematopoietypes of cells. sis, we implanted fragments of healthy adult human bone into NOD/SCID mice. A small fragment of posterior iliac crest was subcutaneously implanted. stained lymphocytes. FACS analysis allows to detect 0.01% of positive cells (Fig. 2) .
Human Hematopoiesis in hu-Bone NOD/SCID Mice
To characterize expression of CD45 on human blood lymphocytes, three populations of cells are analyzed: To detect the presence of human hematopoietic cells in hu-bone NOD/SCID mouse tissues, blood, spleen, lymphocytes (L), monocytes (M), and granulocytes (G) (Fig. 3) . Eighty percent of human blood cells were and bone marrow of the animal retrieved at several time points postimplantation (4, 6, 8, 9, 10, and 12 weeks) stained with anti-CD45 antibody with different fluorescent intensity: fluorescence of lymphocytes is at 10 3 , that were stained with a mouse anti-human CD45 antibody, which is a marker for pan-leucocytes. To identify human of granulocytes at 10 2 , and that of monocytes is at an intermediate value.
cells from mouse cells a scatter dot plot was used, which distinguishes human cells from mouse cells on the basis
Human cells, undetectable at 8 weeks posttransplant, began to emerge at 9 weeks in the blood, the spleen, and of their size (Fig. 1) . The spikes indicate that murine cells and human cells have clearly different sizes on the the bone marrow of some mice (Table 1) . The results of one representative experiment are illustrated in Figure  basis of their SSC and FSC scatters.
To determine the threshold of detection of FACS 4B and D. The human cells constituted 0.65% of circulating mononuclear cells and 0.23% of spleen mononu-analysis, we mixed human lymphocytes stained with a mouse anti-human CD45 antibody FITC with non-clear cells. At 12 weeks, the percentage of human cells found in mouse blood and spleen mononuclear cells was weeks, human bone implant was viable, as shown in Figure 5A . Active osteoblasts, osteocytes, and osteoid-0.1%. The fluorescence intensity of these cells corresponds to that of lymphocytes.
deposited surface were present near the new bone formed (Fig. 5A) . Numerous blood vessels identified by Histology and Immunohistology an anti-von Willebrand factor antibody were observed of Implanted Human Bone in the mouse tissue surrounding the bone implant (Fig.  5C ). The human origin of these vessels was assessed Immunohistological and histological analysis of adult human bone implants in NOD/SCID mice was per-using an anti-human β 2 -microglobulin (specific for HLA class I antigen complex) antibody, which also allows to formed at different times posttransplantation. By 9 demonstrate human hematopoietic foci ( Fig. 5E and B) .
injection of fetal bone marrow cells, have been published (6,7). However, embryonic and adult hemato-Immunostaining with anti-CD45 antibodies revealed that some cells of the hematopoietic foci observed in the hu-poietic progenitors differ with respect to cycling rates, responses profiles to hematopoietic factors, and differen-man bone fragment express CD45 (Fig. 6A) .
tiation capacities (7). Others have reported about trans-Enzymology of Implanted Human Bone plantation of adult human bone into SCID mice. Heike et al.
(3) reported that human hematopoietic cells were Enzymology analysis of adult human bone implants in NOD/SCID mice was performed on cryostat sections. viable in SCID mice only when human cytokines were administered at the site of bone implantation. Fujiki et By 9 weeks, cells of the myeloid lineage (colored in red) were found in the human bone marrow (Fig. 7A) ; they al.
(2) transplanted adult human bone in NOD/SCID mice and described dominant expansion of human T were surrounded by cytoplasmic processes of fibroblastic-like cells that expressed alkaline phosphatase cells with fatty degeneration of marrow in the implanted bone fragment by 8 weeks. (Fig. 7B ).
In this report, we document the successful implanta-DISCUSSION tion of viable human bone into NOD/SCID mice. Osteoblastic cells survived and were functional up to at least Several reports on human hematopoiesis in SCID mice, after implantation of either human fetal bone or 9 weeks as demonstrated by osteoid deposit on the bone surface. The reason for this discrepancy in bone viability hematopoietic cell interactions in vivo. With further efforts to refine the experimental protocol, it will be possi-may result from the origin of transplanted bone. We implanted bone from the posterior iliac crest from healthy ble to extend use of this model to biopsies coming from patients suffering from hematological malignancies. patients rather than rib fragments from patients suffering from cancer, wherein bone marrow could be altered
